Kitagawa, Yuko
Matsuda, Satoru
Gotoda, Takuji
Kato, Ken
Wijnhoven, Bas
Lordick, Florian
Bhandari, Pradeep
Kawakubo, Hirofumi
Kodera, Yasuhiro
Terashima, Masanori
Muro, Kei
Takeuchi, Hiroya
Mansfield, Paul F.
Kurokawa, Yukinori
So, Jimmy
Mönig, Stefan Paul
Shitara, Kohei
Rha, Sun Young
Janjigian, Yelena
Takahari, Daisuke
Chau, Ian
Sharma, Prateek
Ji, Jiafu
de Manzoni, Giovanni
Nilsson, Magnus
Kassab, Paulo
Hofstetter, Wayne L.
Smyth, Elizabeth Catherine
Lorenzen, Sylvie
Doki, Yuichiro
Law, Simon
Oh, Do-Youn
Ho, Khek Yu
Koike, Tomoyuki
Shen, Lin
van Hillegersberg, Richard
Kawakami, Hisato
Xu, Rui-Hua
Wainberg, Zev
Yahagi, Naohisa
Lee, Yeong Yeh
Singh, Rajvinder
Ryu, Min-Hee
Ishihara, Ryu
Xiao, Zili
Kusano, Chika
Grabsch, Heike Irmgard
Hara, Hiroki
Mukaisho, Ken-ichi
Makino, Tomoki
Kanda, Mitsuro
Booka, Eisuke
Suzuki, Sho
Hatta, Waku
Kato, Motohiko
Maekawa, Akira
Kawazoe, Akihito
Yamamoto, Shun
Nakayama, Izuma
Narita, Yukiya
Yang, Han-Kwang
Yoshida, Masahiro
Sano, Takeshi
Article History
Received: 21 November 2023
Accepted: 9 December 2023
First Online: 22 February 2024
Declarations
:
: EPMs and members of the SR team personally disclosed any conflicts of interests in conformity with the regulations of the journal Gastric Cancer. Yuko Kitagawa received grants or contracts from ASAHI KASEI PHARMA CORPORATION, ONO PHARMACEUTICAL CO., LTD., Otsuka Pharmaceutical Factory Inc., Nippon Covidien Inc., TAIHO PHARMACEUTICAL CO., LTD, CHUGAI PHARMACEUTICAL CO., LTD., KAKEN PHARMACEUTICAL CO., LTD., EA Pharma Co., Ltd., Yakult Honsha Co. Ltd., Otsuka Pharmaceutical Co., Ltd. TSUMURA & CO., Sumitomo Pharma Co., Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Takeda Pharmaceutical Co., Ltd., TEIJIN PHARMA LIMITED., Cardinal Health., Kowa Company, Ltd., SYSMEX CORPORATION, and Medicaroid Corporation. Yuko Kitagawa received payment or honoraria from ASAHI KASEI PHARMA CORPORATION, AstraZeneca K.K., Ethicon Inc., ONO PHARMACEUTICAL CO., LTD., Otsuka Pharmaceutical Factory, Inc., Olympus Corporation, Cardinal Health K.K., SHIONOGI & CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, CHUGAI PHARMACEUTICAL CO., LTD., Bristol-Myers Squibb K.K., MSD K.K., Smith & Nephew KK, KAKEN PHARMACEUTICAL CO.,LTD., ASKA Pharmaceutical Co., Ltd., MIYARISAN PHARMACEUTICAL CO. LTD., Toray Industries, Inc., DAIICHI SANKYO COMPANY, LIMITED, Chugai Foundation for Innovative Drug Discovery Science, Nippon Kayaku Co., Ltd., EA Pharma Co.,Ltd., Intuitive Surgical G.K., Takeda Pharmaceutical Company Limited, SYSMEX CORPORATION, and TSUMURA & CO. Satoru Matsuda received received payment or honoraria from MSD, BMS, ONO, Olympus, and Novartis. Takuji Gotoda received payment or honoraria from Fujifilm Co., Fujifilm Medical Co., and Olympus Medical Systems Co.. Ken Kato received consulting fee from ONO, Bristol Myers Squibb, Beigene/ Novartis, Astrazeneca, Roche, BAYER, Merck & Co., Merck bio, and Janssen. Ken Kato received payment or honoraria from ONO, and Bristol Myers Squibb. Florian Lordick received grants or contracts from AstraZeneca, BMS, Daiichi Sankyo, Gilead, and MSD. Florian Lordick received consulting fees from Amgen, Astellas, Astra Zeneca, BMS, Daiichi Sankyo, Gilead, MSD, Novartis, and PAGE. Florian Lordick received payment or honoraria from Art tempi, Astra Zeneca, Bayer, Biontech, BMS, Daiichi Sankyo, Eli Lilly, Falk Foundation, Incyte, MedUpdate, Merck, MSD, Novartis, Roche, Servier, and StreamedUp!. Florian Lordick received travel support from BMS and Daiichi Sankyo. Florian Lordick participated on a Data Safety Monitoring Board or Advisory Board of Biontech. Florian Lordick played leadership or fiduciary role in European Society for Medical Oncology and International Gastric Cancer Association. Yasuhiro Kodera received grants or contracts from Chugai Pharma, Daiichi Sankyo, Otsuka, Taiho Pharma, Abbot, Abbvie, Shionogi, Yakult, Lilly Japan, Pfizer, Ono Pharma, Kaken Pharma, Nihon Kayaku, and Bayyer. Yasuhiro Kodera received payment or honoraria Chugai Pharma, Daiichi Sankyo, Taiho Pharma, Abbvie, Yakult, Lilly Japan, Ono Pharma, Bristol Myers Squibb, Amgen, and MSD. Yasuhiro Kodera participated on a Data Safety Monitoring Board or Advisory Board of Daiichi Sankyo. Masanori Terashima received payment or honoraria from Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol Myers Squib Japan K.K., Yakult Honsha Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Pfizer Japan Inc., Daiichi Sankyo Ltd., Johnson and Johnson K.K., Medtronic Japan Co., Ltd., Intuitive Japan Inc., and Olympus Co., Ltd.. Kohei Shitara received grants or contracts from Astellas Pharma, Ono Pharmaceutical, Daiichi Sankyo, Taiho Pharmaceutical, Chugai Pharma, MSD, Amgen, Eisai, PRA Health Sciences, and Syneos Health. Kohei Shitara received consulting fees from Bristol-Myers Squibb, Takeda Pharmaceuticals, Ono Pharmaceutical, Novartis, Daiichi Sankyo, Amgen, Boehringer Ingelheim, MSD, Astellas, Guardant Health Japan, Janssen, AstraZeneca, Zymeworks Biopharmaceuticals Inc, ALX Oncology Inc., and Bayer. Kohei Shitara received payment or honoraria from Bristol-Myers Squibb, Ono Pharmaceutical, Janssen, Eli Lilly, Astellas, and AstraZeneca. Sun Young RHA received grants or contracts from AstraZeneca, Ono pharmaceutical, Eisai, Ipsen, Merck Sharp and Dohme, Merck KGaA, Pfizer, BeiGene, Astellas Pharma, AMGEN, ALX Oncology, Zymeworks, Macrogenics, Seagen, Bold therapeutics, MedPacto, ABLBIO, Daiichi Sankyo, Taiho Pharmaceutical, Leap therapeutics, and Arcus Biosciences. Sun Young RHA received consulting fees from LG Biochem and Indivumed. Sun Young RHA received payment or honoraria from MSD, Lilly, Daiichi-Sankyo, and Eisai. Sun Young RHA participated on a Data Safety Monitoring Board or Advisory Board of Amgen. Daisuke Takahari received payment or honoraria from Taiho, Eli-lilly, BMS, Daiichi-Sankyo, and Ono. Paulo Kassab received payment or honoraria from Medtronic. Elizabeth Smyth received grants or contracts from BMS and Astra Zeneca. Elizabeth Smyth received consulting fees from Astra Zeneca, BMS, Daiichi Sankyo, Merck, Astellas, Amgen, Novartis, Pfizer, and Viracta. Elizabeth Smyth received payment or honoraria from Astra Zeneca, BMS, Daiichi Sankyo, Merck, Amgen, Novartis, Viracta, Servier, Beigene, and Roche. Elizabeth Smyth received travel support from Mirati. Elizabeth Smyth participated on a Data Safety Monitoring Board or Advisory Board of Beigene, Zymeworks, and Jazz. Elizabeth Smyth played a leadership or fiduciary role in EORTC Gastric Cancer Taskforce Lead, and UKIOG Trustee. Elizabeth Smyth is supported by the NIHR Biomedical Research Centre at Oxford. The views expressed in this article are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Sylvie Lorenzen received consulting fees from Amgen, Astellas, Astra Zeneca, BMS, Daiichi Sankyo, MSD, Novartis, Lilly, and Servier. Sylvie Lorenzen received payment or honoraria from Astra Zeneca, BMS, Daiichi Sankyo, Eli Lilly, Incyte, MSD, Novartis, Servier, StreamedUp, and FOMF. Sylvie Lorenzen received travel support from Daiichi Sankyo. Do-Youn Oh received grants for contracts from AstraZeneca, Novartis, Array, Eli Lilly, Servier, BeiGene, MSD, and Handok. Do-Youn Oh participated on a Data Safety Monitoring Board or Advisory Board of AstraZeneca, Novartis, Genentech/Roche, Merck Serono, Bayer, Taiho, ASLAN, Halozyme, Zymeworks, BMS/Celgene, BeiGene, Basilea, Turning Point, Yuhan, Arcus Biosciences, IQVIA, and MSD. Richard van Hillegersberg received payment or honoraria from Intuitive Surgical. Richard van Hillegersberg played leadership or fiduciary role in ESDE, ISDE, and UGIRA. Hisato Kawakami received grants or contracts from Eisai Co. Ltd.,Taiho Pharmaceutical Co. Ltd, Kobayashi Pharmaceutical. Co., Ltd., Bristol-Myers Squibb Co. Ltd., and Daiichi Sankyo Co. Ltd.. Hisato Kawakami received payment or honoraria from Bristol-Myers Squibb Co. Ltd., Bayer Yakuhin Ltd, Eli Lilly Japan K.K., MSD K.K., Ono Pharmaceutical Co. Ltd, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Merck Biopharma Co., Ltd., Takeda Pharmaceutical Co. Ltd., Yakult Pharmaceutical Industry, Teijin Pharma Ltd, Taiho Pharmaceutical Co. Ltd, and Otsuka Pharmaceutical Co., Ltd.. Min-Hee Ryu received consulting fees from BMS, Lilly, ONO pharmaceutical, MSD, Novartis, Daiichi Sankyo, AstraZeneca, Sanofi, and Astellas. Min-Hee Ryu received payment or honoraria from BMS, Lilly, ONO pharmaceutical, MSD, Novartis, Daiichi Sankyo, AstraZeneca, Sanofi and Astellas. Sho Suzuki received payment or honoraria from FUJIFILM Corporation, FUJIFILM Medical Co., Ltd., Olympus Corporation, MC Medical, Inc, NEC Corporation, Takeda Pharmaceutical Company, and Mochida Pharmaceutical CO.,LTD.. Yang Han-Kwang received grants or contracts from Intuitive Surgical. Paul Mansfield received stock or stock options from Amgen, and Stryker.